Perbedaan Ciputra Development Tbk dan Merck Tbk.: Ciputra Development Tbk diperdagangkan di Rp575 (kapitalisasi pasar 10,38 T, volume 24 jam 4,64 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.830 (kapitalisasi pasar 1,7 T, volume 24 jam 13,3 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 6,1× kapitalisasi pasar Merck Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (4,64 jt vs 13,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | MERK | |
|---|---|---|
Kapitalisasi Pasar | 10,38 T | 1,7 T |
Volume | 4,64 jt | 13,3 rb |
Lot | 46,42 rb | 133 |
Perputaran | 2,66 M | 50,92 jt |
Harga Rata-rata | 574,01 | 3.828,42 |
Nilai Transaksi | 2,66 M | 50,92 jt |
Harga Ekuilibrium Indikatif | 565 | 3.850 |
Volume Ekuilibrium Indikatif | 819 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →